跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PURE-X
首页
药物
PURE-X
PURE-X
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CRYSTALLINE FORMS OF GRAPIPRANT
EP 3113773 B1
申请人: ARATANA THERAPEUTICS INC
优先权: 2014
CN
EP
US
WO
18 件公开
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US 7220742 B2
申请人: BOEHRINGER INGELHEIM INT
优先权: 2005
US
6 件公开
USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED DISORDERS
EP 3442513 B1
申请人: GW RES LTD
优先权: 2016
EP
US
4 件公开
USE OF CANNABIDIVARIN IN THE TREATMENT OF AUTISM SPECTRUM DISORDER, ASSOCIATED DISORDERS AND SCHIZOPHRENIA
EP 3442581 B1
申请人: GW RES LTD
优先权: 2016
EP
US
4 件公开
Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
US 7112674 B2
申请人: SENSIENT IMAGING TECHNOLOGIES
优先权: 2001
US
4 件公开
Medicinal preparation particularly for the treatment of slipped discs hernias
US 2007116647 A1
申请人: THERON JACQUES
优先权: 2002
US
4 件公开
3-(Cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
US 7163957 B2
申请人: PF MEDICAMENT
优先权: 2002
US
4 件公开
Enantiomeric pure beta agonists, manufacturing and use as a medicament thereof
US 7534789 B2
申请人: BOEHRINGER INGELHEIM INT
优先权: 2006
US
4 件公开
Process for the asymmetric hydrogenation of beta-amino ketones
EP 1510517 A1
申请人: LONZA AG
优先权: 2003
CN
EP
US
3 件公开
Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
US 7569549 B2
申请人: PLIVA HRVATSKA D O O
优先权: 2003
EP
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈